Sensitive and Rapid LCMS/MS Method for the Estimation of recently approved Antiviral drugs Maribavir and Fostemsavir in spiked human plasma

Author:

Reddy Vaka Penchala1,Sreenivasa Rao Battula2

Affiliation:

1. Department of Chemistry, GITAM Institute of Science, GITAM (Deemed to be University) Visakhapatnam – 530045.

2. Department of Chemistry, GITAM Institute of Science, GITAM (Deemed to be University) Visakhapatnam – 530045.

Abstract

In this study, a straightforward, highly sensitive, and selective liquid chromatography/tandem mass spectrometry (LC–MS/MS) method was developed and rigorously validated for the simultaneous quantification of Maribavir and Fostemsavir in human plasma. To ensure precision and reliability, we employed Dolutegravir as the internal standard (IS). The analytical process involved a two-step extraction method. Initially, protein precipitation was induced by the addition of acetonitrile, followed by liquid–liquid extraction using a 1:1 (v/v) mixture of diethyl ether and dichloromethane as the extracting solvent. Separation of the analytes was achieved through reversed phase high-performance liquid chromatography (HPLC) using a Phenomenex C18 Luna column (4.6 mm×100 mm, 5 µm). A simple isocratic mobile phase consisting of acetonitrile, methanol, and 0.1% formic acid (35:55:10, v/v) was used, operating at a flow rate of 0.5 mL/min. Under these optimized conditions, the LC chromatogram of the spiked standard exhibited distinct peaks at retention times of 2.07 min, 2.59 min, and 4.29 min for Fostemsavir, Maribavir, and the internal standard, respectively. Detection was performed using a triple quadrupole mass spectrometer employing electrospray ionization in positive ion mode and multiple reaction monitoring (MRM) mode. The mass transitions monitored were m/z 377 → 110, m/z 584 → 105, and m/z 420 → 142 for maribavir, fostemsavir, and dolutegravir, respectively. This method provided a rapid analysis within 5 minutes, over a linear concentration range of 15-750 ng/mL for both maribavir and fostemsavir. Method validation was conducted following FDA guidelines for bio-analytical methods, and the results consistently fell within the acceptable limits for both analytes. Therefore, our developed method holds promise for the accurate analysis of maribavir and fostemsavir in human plasma, and it has potential applications in pharmacokinetic studies

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3